PHARMACIELO LTD (PCLO.CA) Stock Income Statement
Canada - TSX Venture Exchange - TSX-V:PCLO - CA71716K1012 - Common Stock
0.09 CAD
-0.01 (-5.26%)
| TTM (2025-9-30) | 2025 (2025-3-31) | 2024 (2023-12-31) | 2023 (2022-12-31) | 2022 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.83M | 3.97M | 1.54M | 5.31M | 1.95M | |||
| Cost Of Goods | 2.74M | 3.14M | 3.42M | 3.72M | 5.02M | |||
| Gross Profit | 88.50K | 827.60K | -1.88M | 1.59M | -3.07M | |||
| Operating Expenses | 5.10M | 6.63M | 8.67M | 12.12M | 20.89M | |||
| Selling, General, and Administrative Expenses | 4.98M | 6.39M | 8.31M | 11.66M | 19.37M | |||
| Operating Income | -5.01M | -5.80M | -10.56M | -10.53M | -23.96M | |||
| Interest Income/Expense | -1.66M | -4.34M | -2.75M | -2.80M | -1.10M | |||
| Other Income/Expense | 945.20K | 132.70K | 336.40K | 989.70K | -333.00K | |||
| Non Recurring Items | -691.00K | -1.37M | -3.33M | -2.18M | -1.24M | |||
| Income Before Taxes | -6.42M | -11.37M | -16.30M | -14.52M | -26.63M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -6.42M | -11.37M | -16.30M | -14.52M | -26.63M | |||
| EBITDA | -3.86M | -4.16M | -9.14M | -8.95M | -22.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.04 | -0.07 | -0.10 | -0.10 | -0.18 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 3.13% | 20.86% | -122.09% | 29.93% | -158.00% | |||
| Profit Margin | -227.14% | -286.63% | -1057.05% | -273.46% | -1369.14% | |||
| Operating Profit Margin | -177.22% | -146.17% | -684.67% | -198.30% | -1231.80% | |||
All data in CAD